|
RWDD2A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.482000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.204200E-02 |
| Normal-vs-Stage2 |
7.323400E-01 |
| Normal-vs-Stage3 |
7.155000E-01 |
| Normal-vs-Stage4 |
6.128200E-01 |
| Stage1-vs-Stage2 |
5.614800E-01 |
| Stage1-vs-Stage3 |
2.247200E-01 |
| Stage1-vs-Stage4 |
6.308000E-02 |
| Stage2-vs-Stage3 |
9.014600E-01 |
| Stage2-vs-Stage4 |
5.183000E-01 |
| Stage3-vs-Stage4 |
4.586400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.861000E-01 |
| Normal-vs-AfricanAmerican |
8.429200E-01 |
| Normal-vs-Asian |
5.327600E-01 |
| Caucasian-vs-AfricanAmerican |
6.984600E-01 |
| Caucasian-vs-Asian |
6.110200E-01 |
| AfricanAmerican-vs-Asian |
4.920600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.507200E-01 |
| Normal-vs-Female |
2.531000E-01 |
| Male-vs-Female |
7.865400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.043800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.889400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.425800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.464390E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.733240E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.952790E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.320200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.456000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.294800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.003000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.274400E-01 |
| Normal-vs-Grade 2 |
4.179800E-02 |
| Normal-vs-Grade 3 |
1.213400E-01 |
| Normal-vs-Grade 4 |
4.918900E-03 |
| Grade 1-vs-Grade 2 |
7.898000E-01 |
| Grade 1-vs-Grade 3 |
8.982400E-01 |
| Grade 1-vs-Grade 4 |
7.819800E-02 |
| Grade 2-vs-Grade 3 |
7.113200E-01 |
| Grade 2-vs-Grade 4 |
7.62659999999915E-05 |
| Grade 3-vs-Grade 4 |
4.156300E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.59516999999054E-05 |
| Normal-vs-ccB subtype |
1.002960E-01 |
| ccA subtype-vs-ccB subtype |
2.10709999448611E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.020400E-02 |
| Normal-vs-N1 |
2.160800E-01 |
| N0-vs-N1 |
7.975600E-02 |
|
|
